1 / 36

HIV Care Continuum for Persons Living With HIV in Georgia, 2012

Explore the engagement and retention in care stages for persons living with HIV in Georgia in 2012. Learn about antiretroviral therapy utilization, viral suppression rates, and demographic breakdowns by race and gender.

tjasper
Download Presentation

HIV Care Continuum for Persons Living With HIV in Georgia, 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV Care Continuum Persons Living With HIV, Georgia, 2012

  2. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States 82 66 Percent 37 33 25 Hall et al. XIX International AIDS Conference, 2012 ART, antiretroviral therapy

  3. Georgia Care Continuum Methodology,Persons Living With HIV (PLWH), 2012 • Adults and adolescents are those aged >= 13 years • Diagnosed by 09/30/2011 (Western Blot or Viral Load [VL]) , including those missing race, sex, and/or transmission risk • Living as of 12/31/2012 • Current address within Georgia • Engaged in care >= 1 CD4 or VL in 2012 • Retained in care (>= 2 CD4 or VL at least 3 months apart in 2012 • Estimated percentage prescribed ART derived from the Medical Monitoring Project (MMP) Georgia sample • Viral suppression (VS) = VL<200 copies/ml in most recent VL • All percentages are percent of total number of persons diagnosed with HIV

  4. Special consideration: linkage to care within 3 months for prevalent population • HIV reporting began in Georgia 2004; CD4 and viral load (VL) measurements are not available before this date • Linkage to care proxy is CD4 or VL within 3 months of diagnosis date • Linkage is missing for 54% of Georgia’s prevalent HIV population and therefore not represented here • Linkage to care data are included in the New Diagnoses 2011 slide set for persons diagnosed in 2011

  5. Special Consideration: people living with HIV, diagnosed in 2011 • Linkage to care = CD4 or VL within 3 months of diagnosis • For persons diagnosed in 2011, the first CD4 or VL represents linkage to care • CD4 or VL within the first 3 months of diagnosis is excluded from the engagement and retention in care measurements • To allow 12 months for engagement and retention in care and viral suppression, only persons diagnosed by 09/30/2011 and followed through 12/31/12 are included

  6. Adults and adolescents living with HIV, Georgia, 2012 Adults and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 46,495 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Prescribed ART derived from MMP sample Viral suppression (VS) = VL<200 copies/ml Estimated undiagnosed based on CDC projections for proportion undiagnosed nationally

  7. Adults and adolescents living with HIV, by sex, Georgia 2012 Adults and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012 Georgia = 46,495 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Prescribed ART derived from MMP sample Viral suppression (VS) = VL<200 copies/ml Excludes 270 cases for whom sex was not reported

  8. Adults and adolescents living with HIV, by race/ethnicity, Georgia, 2012 Adults and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 46,495 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml *American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <2% of adults living with HIV in Georgia and are grouped with those of mixed or unknown race/ethnicity

  9. Adult and adolescent males living with HIV, by race/ethnicity, Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 34,510 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml *American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <2% of males living with HIV in Georgia and are grouped with those of mixed or unknown race/ethnicity

  10. Adult and adolescent females living with HIV, by race/ethnicity, Georgia 2012 N= 994 N= 8,926 N= 1303 N= 492 Adult and adolescent females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 11,715 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <1% of adults living with HIV in Georgia and are grouped with those of mixed or unknown race/ethnicity

  11. Adults and adolescents living with HIV by current age (years), Georgia 2012 Adults and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 46,495 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  12. Adult and adolescent males living with HIV by current age (years), Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 34,510 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  13. Adult and adolescent females living with HIV by current age (years),Georgia 2012 Adult and adolescent females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 11,715 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  14. Transmission category definitions • Multiple imputation was used to re-distribute transmission category where missing • MSM = Male to male sexual contact • IDU = Injection drug use • MSM/IDU = Male to male sexual contact and injection drug use • HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection • Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  15. Adult and adolescent males living with HIV, by transmission category, Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 34,510 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml Multiple imputation is used to estimate number of persons in each transmission category. *MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  16. Adult and adolescent females living with HIV, by transmission category, Georgia 2012 Adult and adolescent females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 11,715 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml Multiple imputation is used to estimate number of persons in each transmission category. *IDU = Injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  17. Black MSM* living with HIV, by current age (years), Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 15,657 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml Multiple imputation is used to estimate number of persons in each transmission category. *MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  18. White MSM* living with HIV, by current age (years), Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 8,071 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml Multiple imputation is used to estimate number of persons in each transmission category. *MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  19. Hispanic/Latino MSM* living with HIV, by current age (years), Georgia 2012 Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia = 1,670 Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml Multiple imputation is used to estimate number of persons in each transmission category. *MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  20. The HIV Care Continuum can help us… • Focus our efforts for linkage, retention and viral suppression. • Identify groups at increased risk for dropping out of each step in the continuum. • Monitor our progress in improvement of linkage, retention, and viral suppression. • Identify disparities not only in prevalence but in care • Evaluate efforts addressing specific populations with low viral suppression. • Monitor efforts in improving viral suppression in specific counties, census tracts, zip codes and some specific facilities • Encourage improvement in surveillance data completeness (race, sex, transmission category)

  21. Viral suppression (VS) among adults and adolescents engaged and retained in care, by sex, Georgia 2012 N* = 13,160 N* = 71 N* = 4,298 *N= number retained in care Adults and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  22. Viral suppression (VS) among adult and adolescent males engaged and retained in care, by race/ethnicity, Georgia 2012 N* = 893 N* =4,490 N* = 11,236 N* =2,078 *N= number retained in care Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml *American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <2% of males living with HIV in Georgia and are grouped with those of mixed or unknown race/ethnicity

  23. Viral suppression (VS) among adult and adolescent females engaged and retained in care, by race/ethnicity, Georgia 2012 N* = 186 N* = 432 N* = 3,350 N* = 330 *N= number retained in care Adult and adolescent females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml *American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <2% of males living with HIV in Georgia and are grouped with those of mixed or unknown race/ethnicity

  24. Viral suppression (VS) among adults and adolescents engaged and retained in care, by current age (years), Georgia 2012 N* = 7,265 N* = 6,436 N* = 3,486 N* = 639 N* = 2,568 *N= number retained in care Adult and adolescents >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  25. Viral suppression (VS) among adult and adolescent males engaged and retained in care, by current age (years), Georgia 2012 N* = 436 N* = 1,987 N* = 3,223 N* 4,992 N* = 2,522 *N = number retained in care Adult and adolescent males >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  26. Viral suppression (VS) among adult and adolescent females engaged and retained in care, by current age (years), Georgia 2012 N* = 570 N* = 1,157 N* = 200 N* = 1,149 N* = 952 *N= number retained in care Adult and adolescent females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  27. Viral suppression (VS) among adult and adolescent males engaged and retained in care, by transmission category**, Georgia 2012 N* = 9,787 N* = 801 N* = 741 N* = 830 N* 1,001 *N= number retained in care; Males >= age 13, diagnosed by 09/30/2011, living12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012; Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml **MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  28. Viral suppression (VS) among adult and adolescent females engaged and retained in care, by transmission category**, Georgia 2012 N* = 3,129 N* = 907 N*= 262 *N= number retained in care; Females >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012; Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml **HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection IDU = Injection drug use Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

  29. Viral suppression (VS) among Black MSM engaged and retained in care, by current age (years), Georgia 2012 N* = 670 N* = 2,658 N* = 344 N* = 136 N* = 68 *N= number retained in care Adult and adolescent Black MSM >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  30. Viral suppression (VS) among White MSM engaged and retained in care, by current age (years), Georgia 2012 N* = 39 N* = 319 N* = 849 N* = 68 N* = 136 *N= number retained in care Adult and adolescent White MSM >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  31. Viral suppression (VS) among Hispanic/Latino MSM engaged and retained in care, by current age (years), Georgia 2012 N* = 23 N* = 200 N* = 344 N* = 253 N* = 74 *N= number retained in care Adult and adolescent H/L MSM >= age 13, diagnosed by 09/30/2011, living 12/31/2012, Georgia Engaged in care >= 1 CD4 or VL in 2012 Retained in care >= 2 CD4 or VL at least 3 months apart in 2012 Viral suppression (VS) = VL<200 copies/ml

  32. Viral suppression (VS) among adults and adolescents engaged in care, Georgia, 2012, by diagnosis year Adults and adolescent s>= age 13, living 12/31/2012, current address Georgia = 46,495 Engaged in care >= 1 CD4 or VL in 2012 Viral suppression (VS) = VL<200 copies/ml

  33. Limitations • Incomplete reporting • Missing data for race/ethnicity, sex, and current address • Lack of transmission category information • Multiple imputation use to redistribute risk when missing • Definition of heterosexual transmission (sexual contact with a known HIV infected partner or person with increased risk, i.e., MSM or IDU) • Missing laboratory reports may lead to underestimation of engagement, retention and viral suppression • Cannot distinguish lack of prescription of ART, failure of ART adherence, or inappropriate medication choice • Laboratory measures may be a poor proxy for engagement and retention in HIV care

  34. Future analyses • Monitoring the Care Continuum for both the prevalent population andby new diagnoses by year • Advantages of monitoring the Care Continuum for new diagnoses: • Can measure linkage to care for new diagnoses • Excludes older cases who may have moved out of state • May be more sensitive for measuring effectiveness of interventions to improve testing, linkage, engagement and retention in care • Can measure time from diagnosis to viral suppression

  35. Uncertainties • Populations for which data are missing may be fundamentally different • How to obtain data for transgender category • How to improve completeness of reporting • Data on ART use difficult to capture • Understanding barriers to ART adherence • Prioritizing further research

  36. FOR MORE INFORMATION CONTACT: Georgia Department of Public Health HIV/AIDS Epidemiology Program http://health/state.ga.us/epi/hivaids

More Related